Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 antibody test, Vaccination site pain, Vaccination site rash
Clinical narrative: Headache, body aches, injection site soreness, large rash on arm at site of injection (presented 48 hours after injection and lasted for 1 week), tiredness/fatigue, chills, Fever (top temperature of 1; Headache, body aches, injection site soreness, large rash on arm at site of injection (presented 48 hours after injection and lasted for 1 week), tiredness/fatigue, chills, Fever (top temperature of 1; Headache, body aches, injection site soreness, large rash on arm at site of injection (presented 48 hours after injection and lasted for 1 week), tiredness/fatigue, chills, Fever (top temperature of 1; Headache, body aches, injection site soreness, large rash on arm at site of injection (presented 48 hours after injection and lasted for 1 week), tiredness/fatigue, chills, Fever (top temperature of 1; Headache, body aches, injection site soreness, large rash on arm at site of injection (presented 48 hours after injection and lasted for 1 week), tiredness/fatigue, chills, Fever (top temperature of 1; Headache, body aches, injection site soreness, large rash on arm at site of injection (presented 48 hours after injection and lasted for 1 week), tiredness/fatigue, chills, Fever (top temperature of 1; Headache, body aches, injection site soreness, large rash on arm at site of injection (presented 48 hours after injection and lasted for 1 week), tiredness/fatigue, chills, Fever (top temperature of 1; This is a spontaneous report from a contactable consumer (patient herself). A 48-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection) via an unspecified route of administration in arm left on 19Apr2021 11:00 (Lot Number: ER8731, Expiry date: Unknown) (at the age of 48-year-old) as 2nd dose, single dose for COVID-19 immunisation. The patient was not pregnant. Medical history included inappropriate sinus tachacardia, high cholestrol, herpes Type 1, Gerd (gastrooesophageal reflux disease) and known allergies to sulfa. Concomitant medications included omeprazole, fenofibrate, valaciclovir hydrochloride and metoprolol tartrate for an unspecified indication were received within two weeks of vaccination. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection) via an unspecified route of administration in arm left on 29Mar2021 11:00 (Lot Number: ER8733, Expiry date: Unknown) as 1st dose, single dose for COVID-19 immunisation. The patient facility type vaccine was other. The patient didn't receive any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 19 Apr2021, patient reported that headache, body aches, injection site soreness, large rash on arm at site of injection (presented 48 hours after injection and lasted for 1 week), tiredness/fatigue, chills, fever (top temperature of 102.8 degrees 24 hours after vaccination given then gradually decreased). Most side effects resolved after 5 days. Still having low-grade fever (ranging for 99.5 to 100.8) and fatigue since vaccination was received over 6 weeks ago. The patient had lab work completed showing no indication of infection/illness to explain lingerinig fever and fatigue. Post vaccination the patient was tested for COVID-19 on 07May2021 with nasal swab (Lumiradx Sars-Cov-2 AG Test) which result in negative, body temperature included on 19Apr2021, 102.8 and ranging for 99.5 to 100.8 on unspecified date. Therapeutic measures were taken for adverse events and for fever with Tylenol. The outcome of the events was resolved with sequel.